Indicated for: heparin-induced thrombocytopenia; anticoagulation
Route of administration: infusion
Substance: argatroban (anticoagulant)
ATC: B01AE03 (Blood and blood forming organs | Antithrombotic agents | Direct thrombin inhibitors)
Argatroban is an anticoagulant used in the treatment and prevention of thrombosis, particularly in patients with heparin-induced thrombocytopenia (HIT). It is a direct thrombin inhibitor that works by blocking the enzymatic activity of thrombin, thereby preventing blood clot formation.
Argatroban is administered intravenously and is commonly used in critical situations such as deep vein thrombosis or pulmonary embolism, especially in patients who cannot use heparin. The dose is adjusted based on coagulation parameters such as activated clotting time (ACT).
Common side effects include bleeding, nausea, headache, and hypotension. Administration must be performed under strict medical supervision, with careful monitoring of coagulation parameters.
Argatroban is an essential medication for managing thrombotic complications, providing a safe and effective alternative for patients at high risk of thrombosis.